Ads
related to: clinical trials
Search results
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
Morningstar· 3 hours agoREDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, ...
Keymed reports positive efficacy of stapokibart in Phase III clinical trial
Clinical Trials Arena via Yahoo Finance· 2 days agoKeymed Biosciences has reported long-term efficacy and safety data of a Phase III clinical trial of...
Buy Alert: 3 Penny Stocks That Will Explode in 2024
InvestorPlace· 5 hours agoWhen the term penny stocks to buy is thrown around, ideas of high-risk-high-reward, overnight wealth generation and potential scams may come to mind....
Defibrillation Lead Exceeds Expectations in Clinical Trial
Medscape· 5 days agoAn investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has...
Veeva R&D Summit: Automation and AI key in improving development speed
Clinical Trials Arena via Yahoo Finance· 1 day agoCould we use an AI tool to help assess what should be highlighted and making it another step...
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Zacks via Yahoo Finance· 2 hours agoThe company also plans to expand the phase III OCU400 clinical trial in the second half of 2024 to...
ASCO24: BillionToOne unveils results from tumour profiling test comparison
Clinical Trials Arena via Yahoo Finance· 1 hour agoBillionToOne’s Unity foetal antigen non-invasive prenatal test clinical trial assay is being used to...
New Clinical Assessment Tool Improves Dementia Care Actions in Primary Care Patients, NIH Reports
Sierra Sun Times· 1 hour agoJune 5, 2024 – A five-minute cognitive assessment coupled with a decision tree embedded in...
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
Motley Fool via Yahoo Finance· 1 hour agoFor instance, two of Gilead's candidate drugs -- sacituzumab govitecan and magrolimab -- recently...
Wells Fargo raises Annexon stock target on study results, holds Overweight By Investing.com
Investing.com· 3 hours agoOn Wednesday, Wells Fargo (NYSE:WFC) adjusted its outlook on Annexon Biosciences (NASDAQ:ANNX),...